Table 2.
Symptom | Variable | HR† | 95% CI | p Value |
Sepsis | IAH | 3.64 | 2.50 to 5.29 | <0.001* |
Sepsis | 1.30 | 0.94 to 1.81 | 0.112 | |
Interaction | 0.52 | 0.25 to 1.07 | 0.076 | |
Neurological | IAH | 3.27 | 2.25 to 4.76 | <0.001* |
Neurological | 0.99 | 0.67 to 1.46 | 0.95 | |
Interaction | 2.31 | 1.09 to 4.90 | 0.029* | |
CVD | IAH | 3.30 | 2.26 to 4.82 | <0.001* |
CVD | 0.78 | 0.47 to 1.30 | 0.34 | |
Interaction | 3.03 | 1.29 to 7.15 | 0.011* | |
Respiratory | IAH | 3.69 | 2.49 to 5.47 | <0.001* |
Respiratory failure | 1.38 | 0.96 to 1.98 | 0.079 | |
Interaction | 0.73 | 0.37 to 1.48 | 0.39 | |
AKI | IAH | 3.64 | 2.51 to 5.30 | <0.001* |
AKI | 1.01 | 0.71 to 1.42 | 0.97 | |
Interaction | 0.56 | 0.27 to 1.17 | 0.12 |
*p<0.05.
Adjusted for age, gender, APACHE-II score, renal replacement therapy and mechanical ventilation.
AKI, acute kidney injury; CVD, cerebrovascular disease; IAH, intensive care unit-acquired hypernatraemia.